港股早評:三大指數高開,生物醫藥股強勢,寧德時代上市首日開升12.55%
隔夜美股三大指數小幅上升,熱門中概股多數下跌。連跌3日的港股三大指數高開,恒指升0.28%,國指升0.31%,恒生科技指數升0.22%。盤面上,大型科技股多數上升,小米升1.24%,阿里巴巴、快手、京東飄紅,美團跌超1%,騰訊微幅下跌;生物醫藥股集體上升,其中,三生製藥大升近15%,信達生物升4.6%,石藥集團、再鼎醫藥升近4%,百濟神州、翰森製藥、君實生物、遠大醫藥齊升;汽車股普升,Q1營收同比增長187.1%,毛利率創歷史新高,零跑汽車升2.57%,昨日走低的蘋果概念股反彈。寧德時代上市首日開升12.55%。另一方面,體育用品股、鋼鐵股、電子煙概念股走低,波司登、思摩爾國際、重慶鋼鐵股份皆有跌幅。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.